Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
Pre-Market
In 31 days
Vericel is a US-based biopharmaceutical company specializing in the development and commercialization of advanced cell-based therapies and regenerative medicine products. It offers innovative solutions for cartilage repair and the treatment of severe burns, aiming to provide lasting patient benefit.